Departments of Small Animal Clinical Sciences, College of Veterinary Medicine.
ICBR Bioinformatics Core, University of Florida, Gainesville, FL.
J Vet Diagn Invest. 2021 Mar;33(2):261-278. doi: 10.1177/1040638720985242. Epub 2021 Jan 15.
Osteosarcoma (OSA) is a highly aggressive and metastatic neoplasm of both the canine and human patient and is the leading form of osseous neoplasia in both species worldwide. To gain deeper insight into the heterogeneous and genetically chaotic nature of OSA, we applied single-cell transcriptome (scRNA-seq) analysis to 4 canine OSA cell lines. This novel application of scRNA-seq technology to the canine genome required uploading the CanFam3.1 reference genome into an analysis pipeline (10X Genomics Cell Ranger); this methodology has not been reported previously in the canine species, to our knowledge. The scRNA-seq outputs were validated by comparing them to cDNA expression from reverse-transcription PCR (RT-PCR) and Sanger sequencing bulk analysis of 4 canine OSA cell lines (COS31, DOUG, POS, and HMPOS) for 11 genes implicated in the pathogenesis of canine OSA. The scRNA-seq outputs revealed the significant heterogeneity of gene transcription expression patterns within the cell lines investigated (COS31 and DOUG). The scRNA-seq data showed 10 distinct clusters of similarly shared transcriptomic expression patterns in COS31; 12 clusters were identified in DOUG. In addition, cRNA-seq analysis provided data for integration into the Qiagen Ingenuity Pathway Analysis software for canonical pathway analysis. Of the 81 distinct pathways identified within the clusters, 33 had been implicated in the pathogenesis of OSA, of which 18 had not been reported previously in canine OSA.
骨肉瘤(OSA)是犬和人类患者中一种高度侵袭性和转移性的肿瘤,也是这两种物种中最常见的骨肿瘤形式。为了更深入地了解 OSA 的异质性和遗传混乱性质,我们应用单细胞转录组(scRNA-seq)分析了 4 种犬骨肉瘤细胞系。这项 scRNA-seq 技术在犬基因组中的新应用需要将 CanFam3.1 参考基因组上传到分析管道(10X Genomics Cell Ranger)中;据我们所知,这种方法在犬种中以前没有报道过。scRNA-seq 的输出结果通过与逆转录 PCR(RT-PCR)的 cDNA 表达进行比较得到验证,并对 4 种犬骨肉瘤细胞系(COS31、DOUG、POS 和 HMPOS)进行了 Sanger 测序批量分析,共涉及 11 个与犬骨肉瘤发病机制相关的基因。scRNA-seq 的输出结果显示了所研究细胞系(COS31 和 DOUG)内基因转录表达模式的显著异质性。scRNA-seq 数据显示,COS31 中有 10 个独特的类似转录组表达模式簇;在 DOUG 中鉴定出 12 个簇。此外,cRNA-seq 分析为整合到 Qiagen Ingenuity Pathway Analysis 软件进行经典途径分析提供了数据。在这些簇中鉴定出的 81 个不同途径中,有 33 个与 OSA 的发病机制有关,其中 18 个以前在犬骨肉瘤中没有报道过。